Mind Over Matter: Mental Health and Irritable Bowel Syndrome

Review by Prof. Humphrey O'Connor (Ireland)

Study Summary 

Despite being the foremost disorder of gut-brain interaction worldwide, current systems that classify irritable bowel syndrome (IBS) are primarily based on physical bowel symptoms with little reference to psychological comorbidity. A recent paper highlights this discrepancy, and its implications are noteworthy. The study, from six teaching hospitals in the UK, used the statistical technique of latent class analysis to subgroup a cohort of IBS patients (n = 379; mean age, 42.3 yr; 82.8% female), referred from primary care, according to severity of clusters of gastrointestinal and psychological symptoms. Over 12 months of longitudinal follow-up, the patient clusters with higher psychological burden had more severe IBS symptoms, lower quality of life scores, lower rates of discharge from clinic, and higher rates of prescribing of number and types of drugs for IBS. Cluster membership was only assigned at the end of follow-up and did not bias patient management.

Commentary 

This study reiterates the powerful influence of psychology on virtually all aspects of IBS, particularly natural history and prognosis. The study also highlights some of the realities of managing IBS-related psychological comorbidity. For instance, why were rates of referral for psychological therapy unusually similar across patient clusters with high and low psychological burden? Understandably, patients are sometimes ashamed to admit to psychological problems and feel stigmatized by the suggestion of needing psychological or behavioral therapy. Equally, some gastroenterologists may have tunnel vision for gastrointestinal symptoms and are reluctant to broach the sensitive subject of mental illness. Access to effective therapies, even in teaching hospitals, may be limited, where only nine patients (2.4%) were referred for gut-directed hypnotherapy. Given what it predicts in this patient cohort, high psychological burden in IBS is a priority that requires early detection and intervention. Put simply, the authors advocate more personalized holistic management of IBS delivered in a multidisciplinary setting and anchored by an open and trusting physician-patient relationship, therapeutic in itself. Given the potential health and social gain for so many patients, this is an ideal we should all aspire to.

Citation

Goodoory VC, Khasawneh M, Riggott C, et al. Novel symptom subgroups in patients with irritable bowel syndrome are associated with healthcare utilisation in secondary and tertiary care. Aliment Pharmacol Ther 2026;63:1474-1486.